Skip to main content
Erschienen in: World Journal of Urology 3/2016

01.03.2016 | Original Article

Predictors of de novo urge urinary incontinence after photoselective vaporization of the prostate

verfasst von: Jungbum Bae, Hyoun Woo Kang, Hae Won Lee, Kwang Soo Lee, Min Chul Cho

Erschienen in: World Journal of Urology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate serial changes in the incidences of de novo urge urinary incontinence (UUI) after photoselective vaporization of the prostate (PVP) for BPH using a validated questionnaire, OABSS, and to determine predictors of postoperative de novo UUI (dnUUI).

Methods

A total of 84 men, for whom 12-month follow-up data were available and who did not complain of UUI based on the OABSS [score of OABSS question 4 (OABSS4) ≤1], were included in this study. Outcomes were evaluated at 1 week, and 1, 3, 6, and 12 months postoperatively using IPSS, OABSS, and uroflowmetry. The presence of de novo UUI was defined as OABSS4 ≥2 at the follow-up visit.

Results

Maximum flow rate (Qmax), post-void residual urine volume, voiding symptom score, total IPSS, and QOL index improved from 1 week. Storage symptom score and total OABSS improved from 3 months. Incidences of postoperative dnUUI at 1 week, and 1, 3, and 6 months were 42.9, 27.4, 14.3, and 0.0 %, respectively. The decrease in QOL index in patients with dnUUI at each follow-up visit was lesser than in those without dnUUI. On multivariate regression analysis, older age, shorter time to Qmax on baseline uroflowmetry, higher storage symptom score, higher total OABSS, smaller bladder volume at first desire to void, and smaller maximum cystometric capacity (MCC) on baseline urodynamics were independent predictors of occurrence of dnUUI.

Conclusions

Our data indicate that transient dnUUI occurs in a significant proportion of patients after PVP and it tends to decrease over time. Older-aged patients, patients with shorter time to Qmax, higher baseline storage symptom score, higher baseline total OABSS, smaller bladder volume at first desire to void, and smaller MCC may be prone to develop dnUUI postoperatively.
Literatur
1.
Zurück zum Zitat Han E, Black LK, Lavelle JP (2007) Incontinence related to management of benign prostatic hypertrophy. Am J Geriatr Pharmacother 5:324–334CrossRefPubMed Han E, Black LK, Lavelle JP (2007) Incontinence related to management of benign prostatic hypertrophy. Am J Geriatr Pharmacother 5:324–334CrossRefPubMed
2.
Zurück zum Zitat Bruschini H, Simonetti R, Antunes AA, Srougi M (2011) Urinary incontinence following surgery for BPH: the role of aging on the incidence of bladder dysfunction. Int Braz J Urol 37:380–387CrossRefPubMed Bruschini H, Simonetti R, Antunes AA, Srougi M (2011) Urinary incontinence following surgery for BPH: the role of aging on the incidence of bladder dysfunction. Int Braz J Urol 37:380–387CrossRefPubMed
3.
Zurück zum Zitat Rassweiler J, Tebera D, Kuntz R et al (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50:969–979CrossRefPubMed Rassweiler J, Tebera D, Kuntz R et al (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50:969–979CrossRefPubMed
4.
Zurück zum Zitat Chughtai B, Te A (2011) Photoselective vaporization of the prostate for treating benign prostatic hyperplasia. Expert Rev Med Devices 8:591–595CrossRefPubMed Chughtai B, Te A (2011) Photoselective vaporization of the prostate for treating benign prostatic hyperplasia. Expert Rev Med Devices 8:591–595CrossRefPubMed
5.
Zurück zum Zitat Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH (2007) Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 100:593–598CrossRefPubMed Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH (2007) Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 100:593–598CrossRefPubMed
6.
Zurück zum Zitat Pereira-Correia JA, de Moraes Sousa KD, Santos JB et al (2012) GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int 110:1184–1189CrossRefPubMed Pereira-Correia JA, de Moraes Sousa KD, Santos JB et al (2012) GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int 110:1184–1189CrossRefPubMed
7.
Zurück zum Zitat Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA (2006) Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 97:1229–1233CrossRefPubMed Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA (2006) Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 97:1229–1233CrossRefPubMed
8.
Zurück zum Zitat Jeong SJ, Homma Y, Oh SJ (2011) Korean version of the overactive bladder symptom score questionnaire: translation and linguistic validation. Int Neurourol J 15:135–142PubMedCentralCrossRefPubMed Jeong SJ, Homma Y, Oh SJ (2011) Korean version of the overactive bladder symptom score questionnaire: translation and linguistic validation. Int Neurourol J 15:135–142PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Jeong SJ, Homma Y, Oh SJ (2014) Reproducibility study of Overactive Bladder Symptom Score questionnaire and its response to treatment (RESORT) in Korean population with overactive bladder symptoms. Qual Life Res 23:285–292CrossRefPubMed Jeong SJ, Homma Y, Oh SJ (2014) Reproducibility study of Overactive Bladder Symptom Score questionnaire and its response to treatment (RESORT) in Korean population with overactive bladder symptoms. Qual Life Res 23:285–292CrossRefPubMed
10.
Zurück zum Zitat Malek RS, Kuntzman RS, Barrett DM (2000) High power potassium–titanyl-phosphate laser vaporization prostatectomy. J Urol 163:1730–1733CrossRefPubMed Malek RS, Kuntzman RS, Barrett DM (2000) High power potassium–titanyl-phosphate laser vaporization prostatectomy. J Urol 163:1730–1733CrossRefPubMed
11.
Zurück zum Zitat Van Kampen M, De Weerdt W, Van Poppel H, Baert L (1997) Urinary incontinence following transurethral, transvesical and radical prostatectomy. Retrospective study of 489 patients. Acta Urol Belg 65:1–7PubMed Van Kampen M, De Weerdt W, Van Poppel H, Baert L (1997) Urinary incontinence following transurethral, transvesical and radical prostatectomy. Retrospective study of 489 patients. Acta Urol Belg 65:1–7PubMed
12.
Zurück zum Zitat Chang PL, Tsai LH, Huang ST, Wang TM, Hsieh ML, Tsui KH (1998) The early effect of pelvic floor muscle exercise after transurethral prostatectomy. J Urol 160:402–405CrossRefPubMed Chang PL, Tsai LH, Huang ST, Wang TM, Hsieh ML, Tsui KH (1998) The early effect of pelvic floor muscle exercise after transurethral prostatectomy. J Urol 160:402–405CrossRefPubMed
13.
Zurück zum Zitat Latini JM, Giannantoni A (2011) Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder. Expert Opin Pharmacother 12:1017–1027CrossRefPubMed Latini JM, Giannantoni A (2011) Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder. Expert Opin Pharmacother 12:1017–1027CrossRefPubMed
14.
Zurück zum Zitat Porru D, Campus G, Caria A, Madeddu G, Cucchi A, Rovereto B, Scarpa RM, Pili P, Usai E (2001) Impact of early pelvic floor rehabilitation after transurethral resection of the prostate. Neurourol Urodyn 20:53–59CrossRefPubMed Porru D, Campus G, Caria A, Madeddu G, Cucchi A, Rovereto B, Scarpa RM, Pili P, Usai E (2001) Impact of early pelvic floor rehabilitation after transurethral resection of the prostate. Neurourol Urodyn 20:53–59CrossRefPubMed
15.
Zurück zum Zitat Hou CP, Chen TY, Chang CC, Lin YH, Chang PL, Chen CL, Hsu YC, Tsui KH (2013) Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery. Clin Interv Aging 8:667–673PubMedCentralPubMed Hou CP, Chen TY, Chang CC, Lin YH, Chang PL, Chen CL, Hsu YC, Tsui KH (2013) Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery. Clin Interv Aging 8:667–673PubMedCentralPubMed
16.
Zurück zum Zitat Mitropoulos D, Papadoukakis S, Zervas A, Alamanis C, Giannopoulos A (2006) Efficacy of tolterodine in preventing urge incontinence immediately after prostatectomy. Int Urol Nephrol 38:263–268CrossRefPubMed Mitropoulos D, Papadoukakis S, Zervas A, Alamanis C, Giannopoulos A (2006) Efficacy of tolterodine in preventing urge incontinence immediately after prostatectomy. Int Urol Nephrol 38:263–268CrossRefPubMed
Metadaten
Titel
Predictors of de novo urge urinary incontinence after photoselective vaporization of the prostate
verfasst von
Jungbum Bae
Hyoun Woo Kang
Hae Won Lee
Kwang Soo Lee
Min Chul Cho
Publikationsdatum
01.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 3/2016
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1635-z

Weitere Artikel der Ausgabe 3/2016

World Journal of Urology 3/2016 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.